GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease

NCT03320642 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

84

Enrollment

INDUSTRY

Sponsor class

Stopped Study terminated by sponsor

Conditions

Hematologic Malignancies

Interventions

DRUG: Itacitinib
DRUG: Calcineurin inhibitor

Sponsor

Incyte Corporation